Sentinel lymph node biopsy in malignant melanoma

BMJ

Volumn 336, Issue 7650, 2008, Pages 902-903

  Thomas, J Meirion ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; TRACER;

CANCER INCIDENCE; CANCER LOCALIZATION; CANCER SCREENING; CANCER SURVIVAL; EDITORIAL; FALSE POSITIVE RESULT; HISTOPATHOLOGY; HUMAN; IMMUNE SYSTEM; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MELANOMA; MICROMETASTASIS; PALPATION; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; STAINING; ULTRASOUND;

HUMANS; LYMPH NODES; MELANOMA; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; UNNECESSARY PROCEDURES;

EID: 43049141898     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39519.646424.BE     Document Type: Editorial

References (12)

1. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307-17.
2. Kretschmer L, Hilgers R, Mohrle M, Balda BR, Breuninger H, Konz B, et al. Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease. Eur J Cancer 2004;40:212-8.
3. Morton DL, Hoon DS, Cochran AJ, Turner RR, Essner R, Takeuchi H, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003;238:538-49; discussion 549-50.
4. Spanknebel K, Coit DG, Bieligk SC, Gonen M, Rasai J, Klimstra DS. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol 2005;29:305-17.
5. Van Akkooi AC, de Wilt JH, Verhoef C, Schmitz PI, van Geel AN, Eggermont AM, et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol 2006;17:1578-85.
6. Chao C, Martin RCG, Ross MI, Reintgen DS, Edwards MJ, Noyes D. Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 2004;11:259-64.
7. Thomas JM. Prognostic false-positivity in the sentinel node in melanoma. Nat Clinic Pract Oncol 2008;5:18-23.
8. Rossi CR, Mocellin S, Scagnet B, Foletto M, Vecchiato A, Pilati P, et al. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel lymph node biopsy in melanoma patients. J Surg Oncol 2003;83:80-4.
9. Voit CA, van Akkooi AC, Schafer-Hesterberg G, Schoengen A, Sterry W, Eggermont AM. Role of ultrasound (US) and US-guided fine needle aspiration cytology (US-FNAC) prior to sentinel lymph node biopsy (SLNB) in 500 melanoma patients: reduction of need for SLNB by high US-FNAC SN positive identification rate. J Clin Oncol 2007;25(18S):8512.
10. Bafounta ML, Beauchet A, Chagnon S, Saiag P. Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. Lancet Oncol 2004;5:673-80.
11. Kruper L, Botbyl J, Czerniecki B, Elder D, Fraker D, Ming M, et al. Predicting sentinel lymph node status in stage I/II melanoma. J Clin Oncol 2005;23:710s.
12. National Institute for Health and Clinical Excellence. Referral guidelines for suspected cancer. 2005. www.nice.org.uk/CG027.